Form 4: Medtronic CEO Geoffrey Martha Exercises Stock Options and Sells Shares
SEC Form 4
Medtronic's Chairman and CEO, Geoffrey Martha, executed stock options and sold a portion of the acquired shares on June 7, 2024.
Summary
- On June 7, 2024, Geoffrey Martha, Chairman and CEO of Medtronic plc, exercised stock options to acquire 17,519 and 1,594 ordinary shares at a price of $62.76 per share.
- Simultaneously, Martha sold 17,519 shares at $83.76 and 1,594 shares at $83.82.
- Following these transactions, Martha directly owns 143,348 ordinary shares of Medtronic.
- The exercised options were granted on July 28, 2015, and were set to expire on July 28, 2024.
- The reported transactions were filed with the SEC on June 11, 2024.
Sentiment
Score: 5
Explanation: The document is a standard SEC Form 4 filing, reflecting routine transactions. It doesn't inherently convey positive or negative sentiment.
Industry Context
Insider transactions are routinely monitored by investors as they can provide insights into management's perspective on the company's valuation and future prospects. However, option exercises and sales are a normal part of executive compensation.
Stakeholder Impact
- The transactions may have a minor impact on shareholders due to the change in ownership, but the overall effect is likely minimal.
Key Dates
| Date | Description |
|---|---|
| 07/28/2015 | Date stock options were granted. |
| 06/07/2024 | Date of stock option exercise and share sale. |
| 07/28/2024 | Expiration date of the stock options. |
| 06/11/2024 | Date of SEC filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.